Share

Success for platform in digital health

26 May - 2022

Health Integrator launched its digital health platform on February 15, 2021 on behalf of Region Stockholm.
Since then, 28,000 people in Stockholm have registered interest in participating in the program, 8,000 people have taken blood tests and 750 people have met the criteria for participation and started their journey towards better health.
On 14 January 2022, 226 people registered the results of their first follow-up blood tests after six months in the program – representing one tenth of the total length of the program.  

The results in brief:

  • 61% have reduced their long-term blood glucose levels.
  • 43% are now below the prediabetes threshold (42 mmol/mol).
  • 24% have increased their long-term blood glucose levels.
    16 of these participants have reported a value above 47 mmol/mol, i.e.
    a value indicative of type 2 diabetes.
  • 15% have unchanged long-term blood glucose levels.

– It is extremely encouraging to see these results already after 6 months.
In addition, many participants are now initially focusing on areas that only indirectly improve blood sugar levels themselves, such as sleep habits and mental health, which means that it is fully expected that a group of people will continue to increase their values before a long-term improvement occurs,” says Fredrik Söder, CEO of Health Integrator.

A more detailed description of the results is presented here.  For more information: Johan Bloom, Founder and CEO of Curus AB [email protected],+46 733-648 490 About Curus Curus invests in digital health start-ups in the Nordics.
We have 22 companies that we have invested in, such as Mindler, Doctrin, Medicheck, FindOut Diagnostic and others.
See the full list at www.curus.se.
Curus subsidiary Add Health Media is one of the Nordic region’s largest media companies in health and medicine.

More news

7 Nov - 2023

Successful health initiative in Region Stockholm exceeds target – more than 50% out of type 2 diabetes risk zone

20 Sep - 2023

Curus invests in Wellon

4 Sep - 2023

Curus Invests in Measurlabs, a Finnish Laboratory Analysis Platform

This website uses cookies to ensure you get the best experience on our website.